1 / 18

Pharma Licensing Case Studies Pointers

Major Products are Losing Patent Protection with Reformulation Opportunities for Both Innovator and Specialty Pharma. Estimated Annual Sales of Major Brands Losing Patent Protection 1. . ~$96B worth of pharmaceutical products will go off patent from 2007-2012 and by 2016 it will be $140B in sales.2 .

max
Download Presentation

Pharma Licensing Case Studies Pointers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Pharma Licensing – Case Studies & Pointers IP Summit Ireland 2008, February 2008

    2. Major Products are Losing Patent Protection with Reformulation Opportunities for Both Innovator and Specialty Pharma

    3. It is Becoming Increasingly Difficult and Expensive to Develop New Drugs … Reformulations are Cost Effective

    4. Technology Providers can a Play Role in Both Enabling NCE-based Products and Lifecycle Management

    5. Case Studies Based on Different Technologies Developed at Elan

    6. Case Study 1. ProStepTM - nicotine transdermal patch

    7. Case Study 2. Avinza® - once-a-day morphine

    8. Case Study 2. Avinza® - once-a-day morphine Benefits to patients

    9. Case Study 2. Avinza® - once-a-day morphine Benefits to Commercial Partner

    10. Case Study 2. Avinza® - once-a-day morphine

    11. Case Study 3. Emend® (aprepitant) - NCE

    12. Case Study 3. Emend® (aprepitant) - NCE

    16. Case Study 4: Megace® - Lifecycle Management

    17. NanoCrystal® Technology Platform

More Related